|
Volumn 66, Issue 2, 2002, Pages 147-151
|
Treatment of cutaneous leishmaniasis with a topical antileishhmanial drug (WR279396): Phase 2 pilot study
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTILEISHMANIAL AGENT;
PLACEBO;
UNCLASSIFIED DRUG;
WR 279396;
ADULT;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL FEATURE;
CLINICAL TRIAL;
COLOMBIA;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG TOLERABILITY;
EDEMA;
ERYTHEMA;
HUMAN;
MALE;
PAIN;
PHASE 2 CLINICAL TRIAL;
SKIN LEISHMANIASIS;
SOLDIER;
TREATMENT OUTCOME;
LEISHMANIA PANAMENSIS;
PROTOZOA;
|
EID: 0036314069
PISSN: 00029637
EISSN: None
Source Type: Journal
DOI: 10.4269/ajtmh.2002.66.147 Document Type: Article |
Times cited : (73)
|
References (13)
|